Day: June 5, 2020

The Extraordinary General Meeting of Nordic Fibreboard AS (registry code: 11421437, address: Suur-Jõe 48, Pärnu 80042, hereinafter the Company) will be held on the 26thof June 2020 at 11.am at the office of Nordic Fibreboard AS at Suur-Jõe 48, Pärnu.

Nordic Fibreboard AS (registrikood 11421437, asukoht Suur-Jõe 48, Pärnu 80042, edaspidi Selts) aktsionäride erakorraline üldkoosolek toimub 26.juunil 2020. a. kell 11:00 Nordic Fibreboard AS kontoris aadressil Suur-Jõe 48, Pärnu.Üldkoosoleku päevakord ja nõukogu ettepanekud:Nimiväärtuseta aktsia kasutusele võtmine ja põhikirja muutmineNõukogu ettepanek:1)       Võtta kasutusele nimiväärtuseta aktsiad.2)       Nimiväärtuseta aktsia kasutusele võtuga seoses muuta Seltsi põhikirja punkte 2.1, 2.2, 2.3 ning kinnitada need uues sõnastuses alljärgnevalt:2.1. Seltsi miinimumkapital on EUR 100 000 (sada tuhat eurot) ja maksimumkapital on EUR 400 000 (nelisada tuhat eurot).2.2. Seltsi aktsiate miinimumarv on  2 500 000 ja maksimumarv on 10 000 000. Iga aktsia annab aktsionäride üldkoosolekul ühe hääle. Seltsil on ühte liiki aktsiad – nimiväärtuseta...

Dear shareholder!The Management Board of AS Tallinna Sadam, registry code 10137319, address Sadama 25, 15051 Tallinn (hereinafter: Tallinna Sadam), proposes to the shareholders to adopt resolutions of the shareholders without convening a meeting pursuant to § 2991 of the Commercial Code. The proposal to adopt resolutions without convening a general meeting of shareholders is due to the restrictions on organizing meetings in Estonia arising from the COVID-19 pandemic.In order to provide information on the issues to be decided, Tallinna Sadam will organize a webinar on 19.06.2020 at 10:00 am (EET), where Aare Tark, Chairman of the Supervisory Board of Tallinna Sadam; Valdo Kalm, Chairman of the Management Board and Veiko Tali, Chairman of the Nomination Committee will introduce the draft resolutions of the shareholders and answer questions...

Hea aktsionär!ASi Tallinna Sadam, registrikood 10137319, aadress Sadama 25, 15051 Tallinn (edaspidi: Tallinna Sadam), juhatus teeb aktsionäridele ettepaneku aktsionäride otsuste vastuvõtmiseks ilma koosolekut kokku kutsumata vastavalt äriseadustiku §-le 2991. Ettepanek otsuste vastuvõtmiseks ilma aktsionäride üldkoosolekut kokku kutsumata on tingitud COVID-19 pandeemiast tulenevatest koosviibimiste korraldamisele kehtivatest piirangutest Eestis.Otsustamisele pandavate küsimuste osas teabe jagamiseks korraldab Tallinna Sadam 19.06.2020 kell 10.00 veebiseminari, kus Tallinna Sadama nõukogu esimees Aare Tark, juhatuse esimees Valdo Kalm ja nimetamiskomitee esimees Veiko Tali tutvustavad eesti keeles aktsionäride otsuste eelnõude sisu ning vastavad küsimustele. Veebiseminarist võivad Tallinna Sadama youtube’i kanali kaudu osa võtta kõik soovijad....

NEW YORK, NY, June 04, 2020 (GLOBE NEWSWIRE) — ARYA Sciences Acquisition Corp II (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities, today announced the pricing of its initial public offering of 13,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “ARYBU” beginning on June 5, 2020. Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed...

SOUTH SAN FRANCISCO, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 11,000,000 shares of common stock at a public offering price of $14.00 per share. All of the shares of common stock are being offered by AMT. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by AMT, are expected to be $154.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. The shares are expected to begin trading on the Nasdaq Global Select Market on June 5, 2020, under the ticker symbol “AMTI.” The offering is expected to close on June 9, 2020, subject to the satisfaction of customary closing conditions....

VANCOUVER, British Columbia, June 04, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a grant of 1,124,337 stock options to the Chief Operating Officer to replace the same number of previously issued options that expired on May 31, 2020. These stock options are exercisable at a price of $0.09 per share, for a term of eight years. The terms of the stock options granted on June 4, 2020 are in accordance with the Company’s Stock Option Plan.ABOUT AEQUUS PHARMACEUTICALS INC.Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products....

NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICESMISSISSAUGA, Ontario, June 04, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX: KPT) held its Annual Meeting of shareholders today. All candidates proposed as directors were duly elected to the Board of Directors of KPT by a majority of the votes cast by shareholders present or represented by proxy at the Meeting, as follows:    Shareholders present or represented by proxy at the Meeting also approved the appointment of PricewaterhouseCoopers LLP as auditors of KPT (99.31% of votes in favour).About KP Tissue Inc. (KPT)KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 14.8% interest in KPLP. For more information visit www.kptissueinc.com.About...

NON DESTINÉ À LA PUBLICATION AUX ÉTATS-UNIS OU AUX AGENCES DE TRANSMISSION AMÉRICAINESMISSISSAUGA, Ontario, 04 juin 2020 (GLOBE NEWSWIRE) — Papiers Tissu KP Inc. (“PTKP”) (TSX: KPT) a tenu son assemblée annuelle des actionnaires aujourd’hui. Lors de cette assemblée, tous les candidats présentés à titre d’administrateurs ont été dûment élus au conseil d’administration de PTKP par une majorité des voix exprimées par les actionnaires présents en personne ou par procuration, comme suit :Les actionnaires présents en personne ou par procuration à l’assemblée ont également approuvé la nomination de PricewaterhouseCoopers LLP/s.r.l./s.e.n.c.r.l à titre d’auditeurs de PTKP (99,31 % des votes en faveur).À propos de Papiers Tissu KP inc. (PTKP)PTKP a été créée dans le but d’acquérir une participation économique dans PK S.E.C., comptabilisée...

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESCARLSBAD, Calif., June 04, 2020 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces financial results for the year ended December 31, 2019.To our Shareholders:2019 was a record year for Aurora Spine recording the highest revenue in the Company’s history, a 28% increase from the 2018 revenue. During 2019, we continued the integration of our family of products into our Screwless Procedure™, a cutting-edge surgical approach to spine fusion. The Screwless Procedure features: our ZIP® MIS Fusion Systems and our TiNano® Interbody cages.Highlights from 2019     Increase Revenue – During the year, we generated $11.153 million in revenue, the highest revenue in the Company’s history. The change represents an increase...